|
Match
|
Document |
Document Title |
|
|
US20090275923 |
ELECTRONIC CAPSULE FOR TREATING GASTROINTESTINAL DISEASE
The present invention discloses an ingestible capsule containing drug and a method for controlled administration of the drug in a mammal for treatment of a disease of the GI tract. The capsule has...
|
|
|
US20090269399 |
PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF
The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the...
|
|
|
US20090269398 |
Compositions for the encapsulation of natural product extracts in oil medium in hard gelatin capsules and a method of encapsulation
The present invention relates to compositions of natural extracts in oil medium, prepared in non-free-flowing formulations, and encapsuled in hard gelatin capsules, without post-fill sealing. These...
|
|
|
US20090263477 |
SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF
In one aspect, the present invention relates to a formulation in the form of molecular dispersion comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and...
|
|
|
US20090263476 |
Composition of Rapid Disintegrating Direct Compression Buccal Tablet
A composition of a rapidly disintegrating buccal dosage form containing a drug, at least one non-effervescent base such as an alkali metal or alkaline earth metal oxide or hydroxide, and a...
|
|
|
US20090258065 |
Dermatological compositions comprising avermectin nanocapsules
Compositions and nanoemulsions containing lipid nanocapsules dispersed in a hydrophilic phase, such nanocapsules including at least one avermectin compound, are useful for the treatment of...
|
|
|
US20090252787 |
GRANULAR PHARMACEUTICAL COMPOSITIONS
Pharmaceutical compositions comprising a plurality of formulated particles containing at least one active ingredient and at least one pharmaceutically acceptable excipient, granulated with a...
|
|
|
US20090226512 |
Methods and Compositions for Oral Delivery of FTS
Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and...
|
|
|
US20090226511 |
NOVEL PHARMACEUTICAL FORMULATION IN THE FORM OF CELLULOSE CAPSULES SUITABLE FOR BENZIMIDAZOLE DERIVATIVES
A filled cellulose capsule for oral administration, wherein the capsule comprises a cellulose derivative as the base and the filling comprises a therapeutically effective amount of a benzimidazole...
|
|
|
US20090226510 |
PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN
A unit dosage form comprising atorvastatin or a pharmaceutically acceptable salt thereof, prepared without a granulation step, wherein the measured atorvastatin potency of said dosage form shows a...
|
|
|
US20090220590 |
Triple drug combinations for psychiatric patients
The mega capsule can be prescribed by any physician, and in particular those professionals in the psychiatric field. The mega capsule will be a form of medication designed for a specific patient in...
|
|
|
US20090214640 |
DELAYED RELEASE PHARMACEUTICAL ORAL DOSAGE FORM AND METHOD OF MAKING SAME
The present invention relates to a delayed release pharmaceutical oral dosage form and method of making same. The delayed release dosage form comprises one or more active ingredients within a...
|
|
|
US20090208568 |
Gellan Seamless Breakable Capsule and Process for Manufacturing Thereof
The invention relates to a process for manufacturing a seamless breakable capsule, comprising—co-extruding an external and hydrophilic liquid phase, and an internal and lipophilic liquid phase,...
|
|
|
US20090196919 |
OXCARBAZEPINE DOSAGE FORMS
The present invention relates to dosage forms of oxcarbazepine for oral administration that contain oxcarbazepine having a median particle size of from about 14 μm to about 30 μm and to processes...
|
|
|
US20090191265 |
Capsule Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients
A capsule formulation of pirfenidone is provided that includes pharmaceutically acceptable excipients. In one embodiment, this capsule formulation is capable of sustaining desirable pharmacokinetic...
|
|
|
US20090162429 |
Slow-Release Composition, Method for the Preparation Thereof, and Use Thereof
The pharmaceutical or nutraceutical composition with sustained release of an active ingredient according to the present invention comprises at least one coated granule; the coated granule being...
|
|
|
US20090155354 |
DISPENSING ENCAPSULATED LIQUIDS INTO BODY CAVITIES
Body tissue or cavities are treated by inserting a membrane module containing a substance for treating a condition of the cavity or tissue. The substance is enclosed in a membrane that melts,...
|
|
|
US20090117163 |
Composition and Method for the Application of Human Synthetic Pheromones Using Substance Slowly Releasing Technological Bio Capsule in form of Drops in Clothing, Underwear, Jewels and Like
The invention regards a composition for the application of human synthetic pheromones in clothing, underwear, jewels, and like, comprising at least three positive human substances, e.g....
|
|
|
US20090110722 |
Composition
A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also...
|
|
|
US20090098200 |
COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE COMPOUNDS AND METHOD FOR THEIR PREPARATION
Compositions are provided comprising a lipophilic active compound, e.g., a human or veterinary drug or a nutraceutical, interwoven with a polymeric matrix formed by two or more polymers, wherein...
|
|
|
US20090087484 |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
A formulation and dosage form for enhancing the bioavailability of orally administered hydrophilic macromolecules includes a permeation enhancer, a hydrophilic macromolecule, and a carrier such as...
|
|
|
US20090060993 |
SOLID PHARMACEUTICAL COMPOSITION FOR ENHANCED DELIVERY OF COENZYME Q-10 AND UBIQUINONES
The present invention describes a solid oral dosage form of ubiquinones (e.g., ubidecarenone, coenzyme Q-10, idebenone or mixture thereof), providing on contact with water or body fluids the...
|
|
|
US20090041839 |
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN
The present invention provides pharmaceutical compositions comprising an allosteric adenosine A 1 receptor enhancer, such as T-62, in an oral dosage form and processes for the manufacture of such...
|
|
|
US20090041838 |
Anti-Misuse Microparticulate Oral Drug Form
The invention relates to solid microparticulate oral dosage forms having a composition that prevents the misuse of the active pharmaceutical ingredient (API) contained therein. The aim of the...
|
|
|
US20090041829 |
PHARMACEUTICAL DOSAGE FORMS COMPRISING A LIPID PHASE
A tablet for oral administration comprises a lipid phase, comprised to 80% by weight or more by a mixture of (a) triglyceride, (b) mono- or/and diglyceride, and (c) cell membrane lipid; (d) one or...
|
|
|
US20090035368 |
EMBEDDED MICELLAR NANOPARTICLES
The present invention relates to a thermostable solid composition containing nanosized micelles, the micelles containing a poorly soluble chemical substance, such as a biologically active...
|
|
|
US20090035367 |
CONTROLLED DEGRADATION OF EXPANDABLE POLYMERS IN GASTRIC VOLUME REDUCTION TREATMENT
Orally administrable polymer-carrying units for expanding in a stomach of a mammal to fill a space in the stomach, the polymer-carrying units including: a carrier; a plurality of polymer molecules...
|
|
|
US20090028935 |
CARVEDILOL FORMS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF
Disclosed are amorphous carvedilol salt forms, controlled-release carvedilol compositions, and methods of preparing the forms and compositions.
|
|
|
US20090017111 |
TOLTERODINE BEAD
A controlled release tolterodine bead is formed having a microcrystalline cellulose core, a PVP-containing water soluble coating, a tolterodine drug layer, and a controlled release layer.
|
|
|
US20090011009 |
Microspheres comprising nanocapsules containing a lipophilic drug
The present invention provides microspheres comprising a plurality of nanocapsules accommodated in a gel forming polymer, the plurality of nanocapsules comprising an oil core carrying a non...
|
|
|
US20080317790 |
Process for Treatment of Kappa Carrageenan
The present invention relates to a process for treating precipitated carrageenan, comprising the steps of (a) treating the precipitated carrageenan with an aqueous treatment solution containing an...
|
|
|
US20080311188 |
SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING A SIP RECEPTOR AGONIST AND A SUGAR ALCOHOL
A solid pharmaceutical composition suitable for oral administration, comprising:
(a) a S1P receptor agonist; and (b) a sugar alcohol.
|
|
|
US20080311187 |
CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM
The invention relates to a dosage form comprising a physiologically effective amount of a physiologically active substance (A), a synthetic, semi-synthetic or natural polymer (C), optionally one or...
|
|
|
US20080299187 |
Substances for Reducing Occurence of Major Cardiac Events in Humans
A medicament comprising a dispersion of Red Yeast Rice extract in Omega-3 Oils. The medicament is supplied in capsules such that a daily dose is dispensed in an integral number of capsules. A...
|
|
|
US20080292692 |
Impermeable Capsules
A capsule comprising a core and a shell surrounding and enclosing the core, the shell comprising at least one first polymer having a first water solubility parameter, and at least one second...
|
|
|
US20080274174 |
STABLE PANCREATIC ENZYME COMPOSITIONS
Compositions of the present invention, comprising at least one digestive enzyme (e.g., pancrelipase) are useful for treating or preventing disorders associated with digestive enzyme deficiencies....
|
|
|
US20080268038 |
Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
Provided are compositions and methods for increasing diet induced thermogenesis. Typically, the compositions are comprised of L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine,...
|
|
|
US20080268037 |
Autonomous method for oral delivery of a healing substance to a target place in gastrointestinal tract of humans or animals
A method for oral delivery of new drugs, big molecules, proteins, and healing substances to a target place in the body, via digestive tract, using mobile self-controlled capsules with sensors.
|
|
|
US20080260814 |
INJECTION MOULDING PROCESS FOR NEUTRAL AND ACID-GROUP-CONTAINING (METH)ACRYLATE COPOLYMERS
Processes for producing moldings by injection moulding, include melting a mixture made from a (meth)acrylate copolymer and a release agent, devolatilizing the mixture, injecting the molten and...
|
|
|
US20080248102 |
Rapidly Dissolving Pharmaceutical Compositions Comprising Pullulan
The present invention provides an orally dissolving capsule comprising pullulan, a plasticizer and a dissolution enhancing agent.
|
|
|
US20080193519 |
Galenic Applications of Self-Emulsifying Mixtures of Lipidic Excipients
A subject-matter of the invention is novel pharmaceutical formulations which make it possible to improve the intestinal absorption of orally administered active principles, their process of...
|
|
|
US20080187579 |
Extended-release dosage form
Provided are pharmaceutical formulations comprising sustained release particles each having an inner core bead comprising an active pharmaceutical ingredient an intermediate coating substantially...
|
|
|
US20080181932 |
COMPOSITIONS FOR ORAL DELIVERY OF PHARMACEUTICALS
The invention provides methods and compositions for the oral delivery of pharmaceutically active agents. In particular, the compositions generally comprise a plurality of pharmaceutically active...
|
|
|
US20080175898 |
ORAL DRUG CAPSULE COMPONENT INCORPORATING A COMMUNICATION DEVICE
An improved upper capsule portion ( 62 ) of an oral drug delivery capsule ( 60 ) that includes an upper capsule portion ( 62 ) and a lower cup shaped capsule portion ( 64 ), the lower cup shaped...
|
|
|
US20080152704 |
Dosage Forms of Palonosetron Hydrochloride Having Improved Stability and Bioavailability
Provided are solid oral dosage forms of palonosetron hydrochloride, methods of using the dosage forms to treat emesis, and methods of making the dosage forms. The dosage forms have improved...
|
|
|
US20080138404 |
EXTENDED RELEASE FORMULATIONS OF CARVEDILOL
An improved controlled release dosage form for once-daily administration of carvedilol is described. The controlled release dosage form comprises a therapeutically effective amount of carvedilol...
|
|
|
US20080131501 |
Enhanced immediate release formulations of topiramate
The present invention provides enhanced immediate release formulations of topiramate, in which 80% of the active ingredient is released in the period of time of not more than 30 min. These...
|
|
|
US20080118555 |
Stable pharmaceutical composition containing desloratadine
Stable pharmaceutical compositions for oral administration are provided comprising an anti-allergic effective amount of descarbonylethoxy-loratadine or a pharmaceutically acceptable salt thereof, a...
|
|
|
US20080102113 |
Emetic embedded capsule
This invention provides capsules containing an emetic, which capsules can encapsulate a drug, wherein the amount of emetic and the amount of drug is such that the number of capsules needed to be...
|
|
|
US20080095838 |
Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof
The invention relates to an orally-administered, solid pharmaceutical composition comprising, in a single same phase, a lipophilic active principle, a surface active agent, a cationic polymer which...
|